Related references
Note: Only part of the references are listed.Fibrosis in alcoholic and nonalcoholic steatohepatitis
Ramon Bataller et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2011)
Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice
F. W. Kiefer et al.
DIABETOLOGIA (2011)
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Bin Gao et al.
GASTROENTEROLOGY (2011)
Osteopontin is Induced by Hedgehog Pathway Activation and Promotes Fibrosis Progression in Nonalcoholic Steatohepatitis
Wing-Kin Syn et al.
HEPATOLOGY (2011)
Serum Markers of Hepatocyte Death and Apoptosis Are Non Invasive Biomarkers of Severe Fibrosis in Patients with Alcoholic Liver Disease
Vanessa Jeannette Lavallard et al.
PLOS ONE (2011)
Plasma osteopontin concentration correlates with the severity of hepatic fibrosis and inflammation in HCV-infected subjects
Wenbao Huang et al.
CLINICA CHIMICA ACTA (2010)
Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance
Florian W. Kiefer et al.
DIABETES (2010)
Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver disease
Sylvie Naveau et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
Adeline Bertola et al.
PLOS ONE (2010)
Predictive Factors for Pure Steatosis in Alcoholic Patients
Sylvie Naveau et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)
Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity
Adeline Bertola et al.
DIABETES (2009)
Diagnostic and Prognostic Values of Noninvasive Biomarkers of Fibrosis in Patients with Alcoholic Liver Disease
Sylvie Naveau et al.
HEPATOLOGY (2009)
MEDICAL PROGRESS Alcoholic Hepatitis
Michael R. Lucey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests
E. Nguyen-Khac et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Osteopontin expression is required for myofibroblast differentiation
Yair Lenga et al.
CIRCULATION RESEARCH (2008)
Diagnosis and quantitation of fibrosis
Diarmuid S. Manning et al.
GASTROENTEROLOGY (2008)
Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis
Jian Zhao et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Lentiviral-Mediated miRNA Against Osteopontin Suppresses Tumor Growth and Metastasis of Human Hepatocellular Carcinoma
Bing-Sheng Sun et al.
HEPATOLOGY (2008)
Interaction of osteopontin with neutrophil α4β1 and α9β1 integrins in a rodent model of alcoholic liver disease
Atrayee Baneijee et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer
Shashi K. Ramaiah et al.
TOXICOLOGICAL SCIENCES (2008)
Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin
Shigeyuki Kon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection
L. Zhao et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Osteopontin mediates obesity-induced adipose tissue macrophage infiltration and insulin resistance in mice
Takashi Nomiyama et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Gene expression profiles during hepatic stellate cell activation in culture and in vivo
Samuele De Minicis et al.
GASTROENTEROLOGY (2007)
Intrahepatic gene expression in human alcoholic hepatitis
Devanshi Seth et al.
JOURNAL OF HEPATOLOGY (2006)
Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease
A Banerjee et al.
JOURNAL OF PATHOLOGY (2006)
Osteopontin expression in normal and fibrotic liver.: Altered liver healing in. osteopontin-deficient mice
D Lorena et al.
JOURNAL OF HEPATOLOGY (2006)
The temporal expression of osteopontin (SPP-1) in the rodent model of alcoholic steatohepatitis: A potential biomarker
Atrayee Banerjee et al.
TOXICOLOGIC PATHOLOGY (2006)
A novel panel of blood markers to assess the degree of liver fibrosis
P Calès et al.
HEPATOLOGY (2005)
Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis
UM Apte et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases
HY Diao et al.
IMMUNITY (2004)
Massive liver necrosis after provocation of imbalance between Th1 and Th2 immune reactions in osteopontin transgenic mice
S Mimura et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Effects and regulation of osteopontin in rat hepatic stellate cells
SH Lee et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model
A Sahai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis:: role of short-form leptin receptors and osteopontin
A Sahai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Risk factors of fibrosis in alcohol-induced liver disease
B Raynard et al.
HEPATOLOGY (2002)
Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease
A Tran et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2000)
Share Paper
